Barinthus Biotherapeutics (BRNS) EV to Revenue (2021 - 2026)

Barinthus Biotherapeutics (BRNS) EV to Revenue (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EV to Revenue
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 39.46 Mn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 3,065.60
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 42.37
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 8.62
9 Abivax 94.37 Bn 94.37 Bn - 17,434.90
10 Barinthus Biotherapeutics 27.08 Mn -40.03 Mn - -3.31

Historic Data

Download Data
DateValue
Mar 30, 2026 -3.31
Mar 27, 2026 -3.31
Mar 26, 2026 -3.31
Mar 25, 2026 -3.31
Mar 24, 2026 -3.29
Mar 23, 2026 -3.14
Mar 20, 2026 -3.09
Mar 19, 2026 -3.09
Mar 18, 2026 -3.06
Mar 17, 2026 -2.95
Mar 16, 2026 -2.95
Mar 13, 2026 -3.09
Mar 12, 2026 -3.17
Mar 11, 2026 -3.19
Mar 10, 2026 -3.26
Mar 9, 2026 -3.27
Mar 6, 2026 -3.16
Mar 5, 2026 -3.19
Mar 4, 2026 -3.17
Mar 3, 2026 -3.17